Eiger BioPharmaceuticals Inc
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
1.05
-0.04
(-3.67%)
Volume:
398,392
52 week range:
0.96 - 10.02
Market Cap:
46.278M
Company Description:
Eiger is a commercial-stage biopharmaceutical company focused on the development and commercialization of foundational therapies for Hepatitis Delta Virus (HDV) infection, the most serious form of human viral hepatitis.